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ACCIDENTAL INFECTION BY Trypanosoma cruzi FOLLOW-UP BY THE POLYMERASE CHAIN 
REACTION: CASE REPORT 
Andréa Tieko KINOSHITA-YANAGA(1), Max Jean de Ornelas TOLEDO(1), Silvana Marques de ARAÚJO(1), Berenice Pelizza VIER(2) & Mônica Lúcia GOMES(1) 
SUMMARY
We report a case of accidental infection by Trypanosoma cruzi in a 42-year-old female patient who presented an inoculation 
chagoma. Laboratory confirmation was based on examination of fresh blood, Giemsa-stained blood smear, immunoenzyme test 
(EIA-IgG), indirect immunofluorescence (IIF-IgM, IgG) and polymerase chain reaction (PCR). Only the PCR gave a positive result, 
and the EIA test was inconclusive. Two treatments with benznidazole were necessary. PCR was the only technique that continued to 
give positive results for approximately two months (65 days, or 2.2 months) following the second treatment and negative results from 
96 days (3.2 months) to 850 days (28.3 months). We concluded that the presence of an inoculation chagoma and use of PCR were 
important and decisive for diagnosis and follow-up of the case. 
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INTRODUCTION
Infections by Trypanosoma cruzi acquired in laboratory accidents 
have been previously reported7,9,13. Accidents with cutting or piercing 
instruments or from contact with mucosa during manipulation of material 
containing live parasites are high-risk. In such cases, etiological treatment 
must be administered with benznidazole at a dose of 7-10 mg/kg for 
ten days9. After accidental exposure to the parasite, the patient must 
be monitored clinically and through laboratory tests. Serological tests, 
hemoculture and xenodiagnosis are often used for diagnosis and follow-
up of individuals receiving etiological treatment2,4. Early diagnosis of 
infections and better follow-up of etiological treatment are facilitated by 
laboratories where the polymerase chain reaction (PCR) technique2,6,8 is 
available. Here we report the diagnosis, etiological treatment, follow-
up and laboratory confirmation of negativity of an accidental T. cruzi 
infection that occurred in a research laboratory in 2003, through auto-
inoculation of blood trypomastigote forms. The study was approved by 
the Permanent Committee on Ethics Involving Human Beings (Comitê 
Permanente de Ética em Pesquisa Envolvendo Seres Humanos, COPEP) 
of the State University of Maringá (UEM).
CASE REPORT
A 42-year-old female patient residing in Maringá, Paraná State, Brazil, 
sought medical attention at the UEM ambulatory clinic, complaining 
of low fever, fatigue, chronic headache, malaise and depression lasting 
approximately 21 days. When questioned about her profession, the patient 
reported that she had worked for more than 15 years as a technician 
in a laboratory performing research on Chagas’ disease. During the 
examination, she related that three weeks previously she had been involved 
in a laboratory accident with auto-inoculation of trypomastigote forms of 
clone YP3 of T. cruzi strain Y, on the dorsal surface of the left hand at the 
base of the thumb, which she did not consider important at the time. Upon 
clinical examination, the patient was depressed, somewhat apathetic and 
afebrile. There was a discrete left-axillary ganglion swelling, and, near the 
inoculation site, a maculonodular, erythematose, consistent, slightly painful 
formation approximately 2.0 cm in diameter, which was identified by the 
clinic as a possible inoculation chagoma. Upon follow-up, the initial lesion 
slowly regressed with eventual desquamation (Fig. 1).
Following the initial clinical diagnosis, the patient returned to the 
Chagas’ Disease Laboratory (Laboratório de Doença de Chagas, LDC) of 
the UEM and reported the accident. According to the security regulations 
established by the LDC, 15 mL of blood was collected for laboratory 
confirmation, and treatment was immediately initiated with benznidazole 
at a dose of 7 mg/kg/day for 15 days. The patient showed significant 
improvement in her symptoms three to four days after etiological 
treatment, which was considered to be a therapeutic diagnosis. Because 
the PCR remained positive, a second treatment (5 mg/kg/day for 30 days) 
according to the standard plan for cases of acute infection9 was initiated 23 
days after the end of the first treatment. During the treatments, the patient 
reported symptoms possibly related to side effects of the medication, 
such as chronic headache, nausea, generalized discrete edema and a 
dry cough; nevertheless, the treatments were successfully concluded .
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In laboratory confirmation by direct examination of fresh blood, the 
stained blood smear and the indirect immunofluorescence (IIF - IgM 
and IgG - bioMérieux, Brazil) were negative, the enzyme immunoassay 
(EIA - IgG, Chagatest®, Wiener, Argentina) gave an inconclusive result 
(DO = 0.385; Cut-off = 0.347) and the PCR5 using the primers 121 
(5’AAATAATGTACGGG(T/G)GAGATGCATGA3’) and 122 (5’GG
TTCGATTGGGGTTGGTGTAATATA3’) was positive. Eighteen days 
after the first treatment and at different times after the second treatment, 
the serological tests were negative. The only test that allowed us to 
follow this case precisely was the PCR, as can be observed in Fig. 2. 
The PCR remained positive for 36 to 65 days after the second treatment 
(lanes 6 and 7), but the intensity of the 330 bp band was visibly less 
than that observed post-infection (lane 4) and 18 days after the first 
treatment (lane 5). The lower intensity of the 330 bp band may indicate 
a gradual decrease in the number of circulating parasites, because from 
96 days or 3.2 months to 850 days or 28.3 months, this technique gave 
consistently negative results (lanes 8 to 11). Data regarding the dates of 
infection, treatments and results of IIF, EIA and PCR are summarized 
in the Table 1.
Fig. 1 - Inoculation chagoma on the dorsal surface of the left hand at the base of the thumb, 
21 days after accidental inoculation with blood trypomastigote forms of Trypanosoma cruzi 
in a 42-year-old female patient.
Table 1
Results of the tests: indirect immunofluorescence (IIF - IgM and IgG), enzyme immunoassay (EIA) and polymerase chain reaction (PCR) of a case of accidental 
infection by Trypanosoma cruzi in Maringá, Paraná, Brazi
Date Days after 
infection
Treatment Days (months) 
post-treatment
Blood sample EIA -IgG IIF-IgM IIF-IgG PCR
02/10/2003 0 ND
23/10/2003 21 First Beginning D I - - +
06/11/2003 35 End ND
24/11/2003 53 18 (<1) D ND ND - +
29/11/2003 58 Second Beginning ND
28/12/2003 88 End ND
02/02/2004 124 36 (1.2) D - ND - +
02/03/2004 153 65 (2.2) D - ND - +
02/04/2004 184 96 (3.2) D - ND ND -
02/07/2004 275 187 (6.2) D - ND - -
07/01/2005 464 376 (12.5) D ND ND - -
21/03/2006 1412 850 (28.3) D ND ND - -
ND = Not done; D = Done; I = Inconclusive (Do = 0.385 and Cut-off = 0.347); (-) = not reactive or negative; (+) = positive.
Fig. 2 - 4% polyacrylamide gel showing specific 330 bp products (indicated by arrow) of the 
Trypanosoma cruzi kDNA minicircle in the blood of the accidentally infected patient. MWM 
= Molecular Weight Marker 100 bp DNA ladder (Invitrogen); DNA-NC = Negative Control 
of DNA extraction; PCR-NC = Negative Control of PCR; DNA-PC = Positive Control of 
DNA extraction; PCR-PC = Positive Control of PCR; T = Treatment.
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DISCUSSION
Although the patient was an experienced technician in a Chagas’ 
disease research laboratory and knowledgeable about the parasite and 
the necessary safety precautions, she did not relate the clinical signs 
and symptoms to a possible T. cruzi infection. This association was only 
made at the time of the medical consultation. This report can serve as 
one more alert to professionals who work with this parasite. This case 
also reinforces the importance of the history as a diagnostic aid, since 
the presence of nonspecific symptoms may indicate a serious infection 
acquired in a work accident, as in the present case, in which the victim 
assumed that serious consequences would not occur.
Laboratory confirmation of the infection was obtained from the 
positive PCR results. Other tests used were not capable of diagnosing 
the infection, because the results were negative or inconclusive. Several 
workers have shown that in most cases the results of serological tests 
concord with those of the PCR2,3,6, but discordant results of a positive PCR 
with negative or inconclusive serological tests have also been reported2,6,10. 
Some of these workers2 did not exclude the possibility that serologically 
negative individuals with an active T. cruzi infection detected only by 
PCR may be more common than is presently supposed. 
Beside the fresh-blood examination and the Giemsa-stained blood 
smear, no other parasitological test was done to diagnose this infection. 
Although hemoculture is available in our laboratory, this was not used 
because the laboratory is equipped to execute the PCR. This technique 
is more sensitive than hemoculture and xenodiagnosis in detecting 
the presence of T. cruzi2,3,4,6,14. Furthermore, hemoculture shows low 
sensitivity, and requires a long time to process and obtain the results, 
and a large volume of blood2.
Of the alternative tests, PCR best allowed us to follow this case. We 
included a control for contamination, assessed the presence of reaction 
inhibitors, and also included negative and positive controls as described 
by GOMES et al.5. This technique was decisive in indicating the need 
for a second course of treatment, since the first treatment was ineffective. 
This probably occurred because the first treatment was administered 
considering the case as an accidental infection rather than an established 
acute infection, because of the strong impact of the patient’s own report 
and because details of her symptoms were not available at first, only the 
presence of an inoculation chagoma. The PCR remained positive for 36 
to 65 days after the second treatment with amplified product (330 bp), at 
a lower intensity than that observed soon after the infection and 18 days 
after the first treatment. After this result, it remained negative from 3.2 
to 28.3 months after treatment. These data indicate that the number of 
circulating parasites gradually decreased, as reported by MEIRA et al.8, 
that the treatment was effective, and that with the PCR it was possible to 
verify that the parasite had been eliminated. Many reports have shown 
the high sensitivity of PCR in detecting T. cruzi DNA in the blood of 
animals and of etiologically treated patients8,11, indicating therapeutic 
failure or a cure upon follow-up. RIERA et al.14 also emphasized the 
importance of using PCR in cases of congenital transmission, to monitor 
the parasitemia in neonates after etiological treatment. 
Medical expertise, the presence of an inoculation chagoma and 
PCR were important for reaching a correct diagnosis. For follow-up 
after etiological treatment, the PCR was decisive in indicating the need 
for a second course of treatment. The conduct, the follow-up procedure, 
and the demonstration of negativity positively impacted the patient’s 
behavior, emotional state, and continuity of life. This outcome fully 
meets the aims of the LDC, which is to improve the care of patients 
infected with T. cruzi1,12.
RESUMO
Infecção acidental pelo Trypanosoma cruzi acompanhada pela 
reação em cadeia da polimerase: relato de caso 
Reportamos caso de infecção acidental pelo Trypanosoma cruzi 
em paciente do gênero feminino, 42 anos, que apresentou chagoma 
de inoculação. A confirmação laboratorial foi realizada pelo exame de 
sangue a fresco, esfregaço corado com Giemsa, imunoenzimaensaio 
(ELISA-IgG), imunofluorescência indireta (IFI-IgM, IgG) e reação em 
cadeia da polimerase (PCR). Somente a PCR foi positiva e a ELISA foi 
inconclusiva. Dois tratamentos com benznidazol foram necessários. PCR 
foi a única técnica que permaneceu positiva por aproximadamente dois 
meses (65 dias ou 2,2 meses) após o segundo tratamento e negativa de 
96 dias (3,2 meses) a 850 dias (28,3 meses). Concluimos que a presença 
do chagoma de inoculação e o uso da PCR foram importantes e decisivos 
para o diagnóstico e o acompanhamento do caso. 
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